Global Microarray Biochips Market 2022-2026

Global Microarray Biochips Market 2022-2026

Technavio has been monitoring the microarray biochips market and it is poised to grow by $ 14.75 billion during 2022-2026, accelerating at a CAGR of 19.95% during the forecast period. Our report on the microarray biochips market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by an increase in market presence with collaboration strategy, growing used of personalized medicines, and rising demand for microarray biochips in genomics and proteomics.

The microarray biochips market analysis includes application segment and geographic landscape.

Technavio's microarray biochips market is segmented as below:

By Application

• Drug discovery and development
• Diagnostics and treatments
• Research and consumables
• Forensic medicines
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the emerging LOC technology as one of the prime reasons driving the microarray biochips market growth during the next few years. Also, growth in the bioinformatics software industry and the emergence of cost-effective technologies will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the microarray biochips market covers the following areas:

• Microarray biochips market sizing
• Microarray biochips market forecast
• Microarray biochips market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading microarray biochips market vendors that include Abbott Laboratories, Agilent Technologies Inc., Applied Microarrays Inc., Bio Rad Laboratories Inc., BioChain Institute Inc., BioIVT LLC, Biometrix Technology Inc., Danaher Corp., F. Hoffmann La Roche Ltd., Fluidigm Corp., General Electric Co., HORIBA Ltd., Illumina Inc., Merck KGaA, OriGene Technologies Inc., Pantomics Inc., PerkinElmer Inc., Protein Biotechnologies Inc., QIAGEN NV, Randox Laboratories Ltd., RayBiotech Life Inc., Thermo Fisher Scientific Inc., and bioMerieux SA. Also, the microarray biochips market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.